LEP and neoplasm: Simultaneously, leptin-induced inflammatory signaling and adiponectin-suppressed AMPK pathway inactivation collectively promote tumor cell metabolic reprogramming, enhancing their adaptability to hypoxic microenvironments (225, 226).